TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PHAT

Phathom Pharmaceuticals Inc

Healthcare · Biotechnology

7.50$ -3.5% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Phathom Pharmaceuticals Inc (PHAT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/29/2026.

Next report 10/29/2026
Last report 07/30/2026
Earnings surprise by quarter (%)
Q3 23 · 20.8 % 23 Q4 23 · -28.7 % 23 Q1 24 · 9.0 % 24 Q2 24 · -0.8 % 24 Q3 24 · 28.1 % 24 Q4 24 · 2.8 % 24 Q1 25 · -0.4 % 25 Q2 25 · -4.7 % 25 Q3 25 · 63.4 % 25 Q4 25 · 20.0 % 25 Q1 26 · 53.8 % 26 Q2 26 · 46.7 % 26

EPS estimate beaten

Full history 16 of 28 quarters (57%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 04/30/2026 Earnings Call Q1 2026 Open →
  • 02/26/2026 Earnings Call Q4 2025 Open →
  • 10/30/2025 Earnings Call Q3 2025 Open →
  • 08/07/2025 Earnings Call Q2 2025 Open →
  • 05/01/2025 Earnings Call Q1 2025 Open →
  • 03/06/2025 Earnings Call Q4 2024 Open →
  • 11/10/2024 Earnings Call Q3 2024 Open →
  • 08/10/2024 Earnings Call Q2 2024 Open →
  • 05/09/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 07/30/2026 Phathom Pharmaceuticals, Inc. (PHAT): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?